ADAR1 Capital Management »

Adagio Med Hldgs shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Adagio Med Hldgs (ADGM) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Adagio Med Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Adagio Med Hldgs held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Med Hldgs by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $62k 77k 0.80
2024-12-31 $81k 77k 1.05
2024-09-30 $384k 149k 2.58

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Keros Therapeutics (KROS)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Immunovant (IMVT)
89bio (ETNB)
Zai Lab Adr (ZLAB)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Uniqure Nv SHS (QURE)
Prothena Corp SHS (PRTA)
Bridgebio Pharma (BBIO)
Arbutus Biopharma (ABUS)

View all positions for ADAR1 Capital Management

Top funds holding Adagio Med Hldgs

Perceptive Advisors
Adage Capital Partners GP
Rtw Investments
Shaolin Capital Management
Opaleye Management
Affinity Asset Advisors
Geode Capital Management
Vanguard Group
Renaissance Technologies
Toronto-Dominion Bank
Tower Research Capital
UBS Group
Barclays

View all funds holding Adagio Med Hldgs